Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.
All content for The Growth Investor Daily Brief is the property of PodcastAI and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.
Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights
The Growth Investor Daily Brief
5 minutes 45 seconds
11 months ago
Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights
Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem.
The Growth Investor Daily Brief
Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.
